GenUs BioSystems Reduces Yield Requirement For Gene Expression RNA Samples

Sept. 25, 2009 - PRLog -- Northbrook, Illinois  GenUs BioSystems, the leader in research based gene expression analysis, today announced a reduction in the minimum quantity of total RNA necessary for their standard service level. Standard pricing is now available for samples yielding as little as 300 nanograms of total RNA, 70% less than previously offered.

GenUs bioSystems provides the highest quality gene expression analysis available from small and difficult samples such as flourescence-activated cell sorting (FACS), laser capture microdissection (LCM), OCT-embedded, and other biopsy material. GenUs BioSystems special services are available for samples as small as 100 picograms.

Dr. Scott R. Magnuson, president of GenUs BioSystems commented: "GenUs has consistently been able to analyze total RNA samples other labs refuse, providing a much needed service to researchers working with tiny or difficult samples. Currently our standard service provides greater sensitivity and reproducibility than is available from any other source."

About GenUs BioSystems: A service laboratory committed to using state-of-the-art techniques to conduct genomic experiments utilizing microarray technology. GenUs BioSystems standard service includes all materials, processing, quality control, and reporting - including follow-up analysis for a single price. Applications include genomic research, diagnostics,  drug discovery, drug efficacy and toxicity studies, and pharmocogenomics. GenUs BioSystems works with academic, government, industry, and clinical researchers worldwide.

For more information: http://www.genusbiosystems.com

# # #

Contract Laboratory specializing in microarray based gene expression from extremely tiny or difficult to utilize samples. Standard service includes all materials, processing, quality control, and reporting, including follow-up analysis for a single price.